A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects

Conditions: Cardiac Repolarization in Healthy Subjects Interventions: Drug: Carbidopa capsule; Drug: Moxifloxacin Tablets, USP; Drug: Placebo Sponsors: Impax Laboratories, LLC Recruiting

https://clinicaltrials.gov/study/NCT06161220

Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials